USFDA concludes inspection at Aurobindo Pharma Telangana facility with zero observations Ruchika Sharma5 Aug 2023 11:49 AM ISTTelangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (USFDA) has concluded the Pre-Approval Inspection (PAI)...
Granules Pharma successfully completes USFDA inspection with zero observations Ruchika Sharma4 Aug 2023 11:45 AM ISTHyderabad: Granules India Limited, announced that Granules Pharmaceuticals, Inc. (GPI), a wholly owned foreign subsidiary of the company, located in...
USFDA concludes inspection at Gland Pharma Visakhapatnam facility with zero 483 observations Ruchika Sharma31 July 2023 11:27 AM ISTTelangana: Gland Pharma has announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice...
Lupin announces resolution of USFDA warning letter for Goa, Pithampur facilities Ruchika Sharma28 July 2023 12:08 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received correspondence from the US FDA that it has now addressed the concerns...
Aurobindo Pharma arm Telangana facility concludes USFDA inspection with zero observations Ruchika Sharma26 July 2023 2:38 PM ISTHyderabad: Aurobindo Pharma has recently announced that the United States Food and Drug Administration (USFDA) has closed the inspection with zero...
Aurobindo Pharma gets 3 USFDA observations for Telangana facility Ruchika Sharma22 July 2023 1:35 PM ISTTelangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ‘Form 483’ with 3...
USFDA inspection: Biocon Biologics gets 8 observations for Malaysia insulin facility Ruchika Sharma22 July 2023 12:49 PM ISTBengaluru: Biocon Biologics has announced that the U.S. Food and Drug Administration (FDA) conducted two cGMP inspections at Biocon Sdn. Bhd’s...
USFDA concludes inspection at Dr Reddy's Labs Srikakulam facility with zero observations Ruchika Sharma20 July 2023 11:30 AM ISTThe inspection closed with zero observations and a classification of No Action Indicated.
Aurobindo Pharma gets USFDA EIR for Anakapalli facility Ruchika Sharma17 July 2023 11:29 AM ISTHyderabad: Aurobindo Pharma has recently announced that the company has received Establishment Inspection Report from the U.S. Food and Drug...
Gland Pharma gets one 483 Observation from USFDA for Dundigal facility Ruchika Sharma14 July 2023 1:29 PM ISTHyderabad: Gland Pharma today announced that the United States Food and Drug Administration (USFDA) has issued one 483 Observation...
USFDA issues EIR for Granules India Gagillapur facility Ruchika Sharma14 July 2023 12:15 PM ISTTelangana: Indian pharmaceutical company, Graules India Limited, has announced that the US Food and Drug Administration (US FDA) has issued...
USFDA issues two observations for Lupin Nagpur facility Ruchika Sharma13 July 2023 1:04 PM ISTMumbai: Lupin has announced the United States Food and Drug Administration (USFDA) has concluded the inspection at the...
